glp-1 gastric stasis lawsuit in west virginia class action GLP-1 RA michigan glp-1 gastric stasis lawsuit

PubMed: (peer-reviewed) Wang X, et al

Because tirzepatide targets two incretin receptors rather than one, its weight loss trajectory tends to be steeper initially, with greater total weight loss over time compared to semaglutide monotherapy

BPC-157 is stable in gastric acid (unlike most peptides), which is one of its distinguishing pharmacologic properties 1

It is important to disclose all medications, supplements, and herbs you are taking to the healthcare professional before starting the therapy

Lower doses (600mg) show benefit but with reduced magnitude

Peptides are prepared under sterile conditions using laminar flow hoods